Concepedia

Author

Leszek Paradowski

Wroclaw Medical University

Also Known As

L Paradowski, L. PARADOWSKI, L. Paradowski, Leszek Paradowski

118

Publications

1.6K

Citations

21

H-Index

32

Concepts

All Affiliations

Wroclaw Medical UniversityPolish Academy of SciencesUniversity Medical Center GroningenMedical University of BiałystokKU Leuven
LP

About

Leszek Paradowski is an author at Wroclaw Medical University specializing in gastroenterology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

403

2

Health Sciences

2

2

69

3

Epidemiology

2

2

105

4

Allergy

1

1

25

5

Endocrinology

1

1

21

Leszek Paradowski

×

26

Publications

1.4K

Citations

18

H-Index

YearCitations

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou,

Gastroenterology

2016

320

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

William J. Sandborn, Subrata Ghosh, Julián Panés,

Clinical Gastroenterology and Hepatology

2014

295

Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions

W Łaszewicz, Franciszek Iwańczak, Barbara Iwańczak,

Advances in Medical Sciences

2014

80

Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome ‐ a randomized, double‐blind, placebo‐controlled study

Tibor Wittmann, Leszek Paradowski, Philippe Ducrotté,

Alimentary Pharmacology & Therapeutics

2010

74

Enhanced formation of advanced oxidation protein products in IBD

Małgorzata Krzystek‐Korpacka, Katarzyna Neubauer, Izabela Berdowska,

Inflammatory Bowel Diseases

2008

67

Paraoxonase-1 status in Crohnʼs disease and ulcerative colitis

Dorota Boehm, Małgorzata Krzystek‐Korpacka, Katarzyna Neubauer,

Inflammatory Bowel Diseases

2008

55

Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: Impact of anemia and treatment

Małgorzata Krzystek‐Korpacka, Katarzyna Neubauer, Izabela Berdowska,

Inflammatory Bowel Diseases

2010

54

Gastroesophageal Reflux Disease and Physical Activity

Paweł Jóźków, Dorota Waśko−Czopnik, M Medraś,

Sports Medicine

2006

48

Stool patterns and symptoms of disordered anorectal function in patients with inflammatory bowel diseases

Paweł Petryszyn, Leszek Paradowski

Advances in Clinical and Experimental Medicine

2018

46

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohnʼs disease†

C. Janneke van der Woude, Pieter Stokkers, Ad A. van Bodegraven,

Inflammatory Bowel Diseases

2010

45

Page 1